UNOMEDICAL A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About UNOMEDICAL A/S
UNOMEDICAL A/S (CVR number: 64153315) is a company from LEJRE. The company reported a net sales of 2646.7 mDKK in 2023, demonstrating a growth of 3.2 % compared to the previous year. The operating profit percentage was at 26.5 % (EBIT: 702.3 mDKK), while net earnings were 534.6 mDKK. The profitability of the company measured by Return on Assets (ROA) was 30.3 %, which can be considered excellent and Return on Equity (ROE) was 26.5 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 69.8 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. UNOMEDICAL A/S's liquidity measured by quick ratio was 0.3 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 1 721.63 | 1 980.46 | 2 115.52 | 2 563.87 | 2 646.66 |
Gross profit | 820.96 | 913.09 | 950.61 | 1 103.39 | 905.60 |
EBIT | 677.04 | 746.89 | 741.08 | 880.86 | 702.27 |
Net earnings | 520.36 | 587.36 | 596.55 | 2 403.88 | 534.58 |
Shareholders equity total | 2 082.33 | 2 671.02 | 2 672.53 | 2 204.75 | 1 831.69 |
Balance sheet total (assets) | 2 930.98 | 3 532.12 | 3 428.71 | 2 735.34 | 2 622.43 |
Net debt | 122.58 | 328.20 | |||
Profitability | |||||
EBIT-% | 39.3 % | 37.7 % | 35.0 % | 34.4 % | 26.5 % |
ROA | 23.1 % | 23.1 % | 21.3 % | 87.7 % | 30.3 % |
ROE | 14.3 % | 24.7 % | 22.3 % | 98.6 % | 26.5 % |
ROI | 23.1 % | 23.1 % | 21.3 % | 92.8 % | 35.1 % |
Economic value added (EVA) | 598.73 | 642.25 | 606.86 | 588.94 | 302.80 |
Solvency | |||||
Equity ratio | 100.0 % | 100.0 % | 100.0 % | 80.6 % | 69.8 % |
Gearing | 5.9 % | 18.3 % | |||
Relative net indebtedness % | 18.3 % | 27.3 % | |||
Liquidity | |||||
Quick ratio | 0.9 | 0.3 | |||
Current ratio | 2.0 | 1.0 | |||
Cash and cash equivalents | 7.19 | 7.87 | |||
Capital use efficiency | |||||
Trade debtors turnover (days) | 54.5 | 23.2 | |||
Net working capital % | 18.1 % | -1.3 % | |||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | A | AA |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.